ABB Ltd: Form 20-F for the period ended Dec 31, 2019
Filed with the SEC on Feb 26, 2020 and accepted by EDGAR at Feb 25, 2020, 12:50 ET.
Sections
Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. The main document on sec.gov.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2019-12-31. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 12 months2019-01-01 to 2019-12-31 | $27.98bn | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 12 months2019-01-01 to 2019-12-31 | $19.07bn | us-gaap:CostOfRevenue |
| Gross profit | 12 months2019-01-01 to 2019-12-31 | $8.91bn | us-gaap:GrossProfit |
| Research and development | 12 months2019-01-01 to 2019-12-31 | $1.20bn | us-gaap:ResearchAndDevelopmentExpense |
| Selling, general and administrative | 12 months2019-01-01 to 2019-12-31 | $5.45bn | us-gaap:SellingGeneralAndAdministrativeExpense |
| Operating income | 12 months2019-01-01 to 2019-12-31 | $1.94bn | us-gaap:OperatingIncomeLoss |
| Income tax | 12 months2019-01-01 to 2019-12-31 | $772.0m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 12 months2019-01-01 to 2019-12-31 | $1.53bn | us-gaap:ProfitLoss |
| Diluted EPS | 12 months2019-01-01 to 2019-12-31 | $0.67 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 12 months2019-01-01 to 2019-12-31 | $0.67 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 12 months2019-01-01 to 2019-12-31 | 2,135,000,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 12 months2019-01-01 to 2019-12-31 | $2.33bn | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 12 months2019-01-01 to 2019-12-31 | $762.0m | us-gaap:PaymentsToAcquireProductiveAssets |
| Dividends paid | 12 months2019-01-01 to 2019-12-31 | $1.68bn | us-gaap:PaymentsOfDividendsCommonStock |
| Share repurchases | 12 months2019-01-01 to 2019-12-31 | $0 | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2019-12-31 | $3.54bn | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2019-12-31 | $26.46bn | us-gaap:AssetsCurrent |
| Total assets | At period end2019-12-31 | $46.11bn | us-gaap:Assets |
| Current liabilities | At period end2019-12-31 | $20.27bn | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2019-12-31 | $32.13bn | us-gaap:Liabilities |
| Long-term debt | At period end2019-12-31 | $6.77bn | us-gaap:LongTermDebtNoncurrent |
| Current portion of debt | At period end2019-12-31 | $1.45bn | us-gaap:LongTermDebtCurrent |
| Short-term borrowings | At period end2019-12-31 | $838.0m | us-gaap:ShortTermBorrowings |
| Shareholders' equity | At period end2019-12-31 | $13.53bn | us-gaap:StockholdersEquity |
| Shares outstanding | At period end2019-12-31 | 2,133,501,111 shares | dei:EntityCommonStockSharesOutstanding |
Source: SEC EDGAR, the filing index for accession 0001104659-20-024879. Last ingested by Listed: Oct 24, 2026, 15:02 ET. Listed shows no prices and gives no investment advice.